Suven Life Sciences Limited
SUVEN · 530239 · Healthcare · Healthcare Research, Analytics & Technology
- Market cap
- Rs 8,844 Cr
- P/E
- —
- P/B
- 14.95x
- 52W high / low
- Rs 403.35 / Rs 124.11
operating_margin -3991.51% exceeds +/-100%, which is either a genuine outsized margin (e.g. a loss exceeding revenue) or a near-zero revenue denominator; flagged for review. net_margin -3998.70% exceeds +/-100%, which is either a genuine outsized margin (e.g. a loss exceeding revenue) or a near-zero revenue denominator; flagged for review. BSE's published operating_margin (-620.13%) exceeds the +/-100% plausibility bound; the source value is retained with a machine-readable warning. BSE's published net_margin (-734.67%) exceeds the +/-100% plausibility bound; the source value is retained with a machine-readable warning. Our computed roe (-100.50%) diverges from BSE's own published figure (-6.63%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Syngene International Limited | Rs 367.2 | Rs 15,288 Cr | Rs 3,679 Cr | Rs 221 Cr | 68.85x | 4.62% |
| Indegene Limited | Rs 605.15 | Rs 14,645 Cr | Rs 3,892 Cr | Rs 401 Cr | 36.44x | 10.39% |
| Suven Life Sciences LimitedThis company | Rs 324.75 | Rs 8,844 Cr | Rs 29.7 Cr | Rs -352.4 Cr | — | -100.50% |
| Vimta Labs Limited | Rs 591.4 | Rs 1,331 Cr | Rs 339 Cr | Rs 61.4 Cr | 44.96x | 20.41% |
| Median | Rs 598.28 | Rs 7,988 Cr | Rs 2,115 Cr | Rs 231 Cr | 40.70x | 15.40% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.